Identification of new splice sites used for generation of rev transcripts in human immunodeficiency virus type 1 subtype C primary isolates

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Delgado, Elena ^a   Carrera, Cristina ^a   Nebreda, Paloma ^a   Fernández García, Aurora ^a   Pinilla, Milagros ^a   García, Valentina ^a   Pérez Álvarez, Lucía ^a   Thomson, Michael M ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE; REV PROTEIN; VIRUS RNA; MESSENGER RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CLADISTICS; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; PANDEMIC; PERIPHERAL BLOOD MONONUCLEAR CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; RNA SPLICING; SEQUENCE ANALYSIS; VIRUS IDENTIFICATION; VIRUS ISOLATION; COMPUTER PROGRAM; EXON; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTRON; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; VIROLOGY;

BASE SEQUENCE; EXONS; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HUMANS; INTRONS; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; RNA SPLICE SITES; RNA SPLICING; RNA, MESSENGER; RNA, VIRAL; SOFTWARE;

EID: 84857151108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030574     Document Type: Article

References (52)

1. Schwartz SB, Felber K, Benko DM, Fenyö EM, Pavlakis GN, (1990) Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J Virol 64: 2519-2529.
2. Purcell DF, Martin M, (1993) Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 67: 6365-6378.
3. Benko DM, Schwartz S, Pavlakis GN, Felber BK, (1990) A novel human immunodeficiency virus type 1 protein, tev, shares sequences with tat, env, and rev proteins. J Virol 64: 2505-2518.
4. Salfeld JH, Göttlinger G, Sia RA, Park RE, Sodroski JG, et al. (1990) A tripartite HIV-1 tat-env-rev fusion protein. EMBO J 9: 965-970.
5. Furtado MR, Balachandran R, Gupta P, Wolinski SM, (1991) Analysis of alternatively spliced human immunodeficiency virus type-1 mRNA species, one of which encodes a novel Tat-Env fusion protein. Virology 185: 258-270.
6. Smith J, Azad J, Deacon N, (1992) Identification of two novel human immunodeficiency splice acceptor sites in infected T cell lines. J Gen Virol 73: 1825-1828.
7. Berkhout B, van Wamel JLB, (1996) Identification of a novel splice acceptor in the HIV-1 genome: independent expression of the cytoplasmic tail of the envelope protein. Arch Virol 141: 839-855.
8. Bilodeau PS, Domsic JK, Stoltzfus CM, (1999) Splicing regulatory elements within tat exon 2 of human immunodeficiency virus type 1 (HIV-1) are characteristic of group M but not group O HIV-1 strains. J Virol 73: 9764-9772.
9. Lützelberger ML, Reinert S, Das AT, Berkhout B, Kjems J, (2006) A novel splice donor site in the gag-pol gene is required for HIV-1 RNA stability. J Biol Chem 281: 18644-18651.
10. Carrera C, Pinilla M, Pérez-Álvarez L, Thomson MM, (2010) Identification of unusual and novel HIV type 1 spliced transcripts generated in vivo. AIDS Res Hum Retroviruses 26: 815-820.
11. Staffa A, Cochrane A, (1994) The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3′ splice site. J Virol 68: 3071-3079.
12. O'Reilly MM, McNally T, Beemon KL, (1995) Two strong 5′ splice sites and competing, suboptimal 3′ splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology 213: 373-385.
13. Si ZB, Amendt A, Stoltzfus CM, (1997) Splicing efficiency of human immunodeficiency virus type 1 tat RNA is determined by both a suboptimal 3′ splice site and a 10 nucleotide exon splicing silencer element located within tat exon 2. Nucleic Acids Res 25: 861-867.
14. Swanson AK, Stoltzfus CM, (1998) Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs. J Biol Chem 273: 34551-34557.
15. Madsen JM, Stoltzfus CM, (2006) A suboptimal 5′ splice site downstream of HIV-1 splice site A1 is required for unspliced viral mRNA accumulation and efficient virus replication. Retrovirology 3: 10.
16. Stoltzfus CM, (2009) Regulation of HIV-1 alternative splicing and its role in virus replication. Adv Virus Res 74: 1-40.
17. Madsen JM, Stoltzfus CM, (2005) An exonic splicing silencer downstream of the 3′ splice site A2 is required for efficient human immunodeficiency virus type 1 replication. J Virol 79: 10478-10486.
18. Hemelaar J, Gouws E, Ghys PD, Osmanov S, WHO-UNAIDS Network for HIV Isolation and Characterisation (2011) Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25: 679-689.
19. Cuevas MT, Fernández-García A, Pinilla M, García-Alvarez V, Thomson M, et al. (2009) Biological and genetic characterization of HIV type 1 subtype B and nonsubtype B transmitted viruses: usefulness for vaccine candidate assessment. AIDS Res Hum Retroviruses 26: 1019-1025.
20. Fernández-García A, Cuevas MT, Muñoz-Nieto M, Ocampo A, Pinilla M, et al. (2009) Development of a panel of well-characterized human immunodeficiency virus type 1 isolates from newly diagnosed patients including acute and recent infections. AIDS Res Hum Retroviruses 25: 93-102.
21. Gao K, Masuda A, Matsuura T, Ohno K, (2008) Human branch point consensus sequence is yUnAy. Nucleic Acids Res 36: 2257-2267.
22. Corvelo A, Halleger M, Smith CWJ, Eyras E, (2010) Genome-wide association between branch point properties and alternative splicing. PLoS Comput Biol 6: e1001016.
23. HIV Sequence Database Los Alamos National Laboratory. Available: http://www.hiv.lanl.gov/content/sequence/HIV/mainpage.html. Accessed 2011 Mar 10.
24. Wu J, Manley JL, (1989) Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing. Genes Dev 3: 1553-1561.
25. Nelson KK, Green MR, (1989) Mammalian U2 snRNP has a sequence-specific RNA-binding activity. Genes Dev 3: 1562-1571.
26. Reed R, (1989) The organization of 3′ splice-site sequences in mammalian introns. Genes Dev 3: 2113-2123.
27. Roscigno RF, Weiner M, Garcia-Blanco M, (1993) A mutational analysis of the polypyrimidine tract of introns. J Biol Chem 15: 11222-1229.
28. Norton PA, (1994) Polypyrimidine tract sequences direct selection of alternative branch sites and influence protein binding. Nucleic Acids Res 22: 3854-3860.
29. Coolidge CJ, Seely RJ, Patton JG, (1997) Functional analysis of the polypyrimidine tract in pre-mRNA splicing. Nucleic Acids Res 25: 888-896.
30. Buvoli M, Mayer SA, Patton JG, (1997) Functional crosstalk between exon enhancers, polypyrimidine tracts and branchpoint sequences. EMBO J 16: 7174-7183.
31. Lear AL, Eperon LP, Wheatley IM, Eperon IC, (1990) Hierarchy for 5′ splice site preference determined in vivo. J Mol Biol 211: 103-115.
32. Roca X, Sachidanandam R, Krainer AR, (2005) Determinants of the inherent strength of human 5′ splice sites. RNA 11: 683-698.
33. Smith CW, Chu TT, Nadal-Ginard B, (1993) Scanning and competition between AGs are involved in 3′ splice site selection in mammalian introns. Mol Cell Biol 13: 4939-4952.
34. Kol G, Levy-Maor G, Ast G, (2005) Human-mouse comparative analysis reveals that branch-site plasticity contributes to splicing regulation. Hum Mol Genet 14: 1559-1568.
35. Zhuang Y, Goldstein AM, Weiner AM, (1989) UACUAAC is the preferred branch site for mammalian mRNA splicing. Proc Natl Acad Sci USA 86: 2752-2756.
36. Caputi M, Freund M, Kammler S, Asang C, Schaal H, (2004) A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates HIV-1 rev, env, vpu, and nef gene expression. J Virol 78: 6517-6526.
37. Borensztajn KM, Sobrier L, Duquesnoy P, Fischer AM, Tapon-Bretaudière J, et al. (2006) Oriented scanning is the leading mechanism underlying 5′ splice site selection in mammals. PLoS Genet 2: e138.
38. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, et al. (2001) Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull 58: 19-42.
39. Verhoef K, Klein A, Berkhout B, (1996) Paracrine activation of the HIV-1 LTR promoter by the viral Tat protein is mechanistically similar to trans-activation within a cell. Virology 225: 316-327.
40. Montano MA, Nixon CP, Essex M, (1998) Dysregulation through the NF-κB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter. J Virol 72: 8446-8452.
41. Montano MA, Nixon CP, Ndung'u T, Bussmann H, Novitsky VA, et al. (2000) Elevated tumor necrosis factor-alpha activation of human immunodeficiency virus type 1 subtype C in Southern Africa is associated with an NF-κB enhancer gain-of-function. J Infect Dis 181: 76-81.
42. Quivy V, Adam E, Collette Y, Demonte D, Chariot A, et al. (2002) Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-κB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. J Virol 76: 11091-11103.
43. Lemieux AM, Pare ME, Audet B, Legault E, Lefort S, et al. (2004) T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-κB and NFAT with its enhancer region. J Biol Chem 279: 52949-52960.
44. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, (2000) Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 74: 3740-3751.
45. Ball SC, Abraha A, Collins KR, Marozsan AJ, Baird H, et al. (2003) Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. J Virol 77: 1021-1038.
46. Arien KK, Abraha A, Quiñones-Mateu ME, Kestens L, Vanham G, et al. (2005) The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol 79: 8979-8990.
47. Tscherning C, Alaeus A, Fredriksson R, Bjorndal A, Deng H, et al. (1998) Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology 241: 181-188.
48. Abebe A, Demissie D, Goudsmit J, Brouwer M, Kuiken CL, et al. (1999) HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS. AIDS 13: 1305-1311.
49. Bjorndal A, Sonnerborg A, Tscherning C, Albert J, Fenyo EM, (1999) Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS Res Hum Retroviruses 15: 647-653.
50. Kaleebu P, Nankya IL, Yirrell DL, Shafer LA, Kyosiimire-Lugemwa J, et al. (2007) Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: results from a rural Ugandan cohort. J Acquir Immune Defic Syndr 45: 28-33.
51. Huang W, Eshleman SH, Toma J, Fransen S, Stawiski E, et al. (2007) Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations. J Virol 81: 7885-7893.
52. Iordanskiy, Waltke M, Feng Y, Wood C, (2010) Subtype-associated differences in HIV-1 reverse transcription affect the viral replication. Retrovirology 7: 85.